Akari Therapeutics, Plc (AKTX) Stock Sliding in Aftermarket Trading Session
Akari Therapeutics, Plc (AKTX), a clinical-stage biopharmaceutical company, has plunged 11.33% in aftermarket trading session. As a result, AKTX stock is trading at $1.33 at the time of the writing. On Friday, AKTX closed the day at $1.50 after surging by 8.70% during regular trading hours. The last press release from the company was about […]